← Leaderboards
Leyla S Diaz
Functional Genetics, Inc.
$2,767,318
Attributed
$2,767,318
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $995.2K · FY2010–12$1M$750K$500K$250K$0
'10
'11
'12
Funding mix
By agency
NIH$2,767,318 · 1
By mechanism
R44$2,767,318 · 1
Top collaborators
No co-investigators on record.
Most similar at Functional Genetics, Inc.
Same institution · by research overlap
- Wu-Bo Li$2,883,302
- Hanwen Mao$599,248
Others in their field
Top investigators on “Adult”
- Lawrence Corey · Fred Hutchinson Cancer Center$594,628,824
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$397,114,680
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$388,038,550
- Judith S. Currier · University Of California Los Angeles$251,592,913
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$196,603,707
- Carol Nesel · Westat$188,148,170
Research focus
AdultAffinityAnimalsAntibodiesAntibody -Dependent Cell CytotoxicityAntibody FormationAnti-Hiv AgentsAnti-Retroviral AgentsAntiviral AgentsAnti-Viral EfficacyAntiviral TherapyBacteriophagesBaseBinding (Molecular Function)BiologicalCcr5 GeneCd4 Positive T LymphocytesCellsCell SurvivalCellular TargetingCommunicable DiseasesCommunitiesComplement-Dependent CytotoxicityAcquired Immunodeficiency Syndrome
Grant awards (3)
Discovery of Critical Host Genes Enabling Resistance to HIV-1 Infection as Therap$914,355
R44 · FY2012 · AI · contact PI
Discovery of Critical Host Genes Enabling Resistance to HIV-1 Infection as Therap$995,189
R44 · FY2011 · AI · contact PI
Discovery of Critical Host Genes Enabling Resistance to HIV-1 Infection as Therap$857,774
R44 · FY2010 · AI · contact PI